Kelekci, S.Sen, V.Yolbas, I.Uluca, U.Tan, I.Gurkan, M. F.2024-04-242024-04-2420131128-3602https://hdl.handle.net/11468/20921BACKGROUND: Prolonged cough in children is one of the major complaints seen in hospitals. It is difficult to make a proper diagnosis and start the appropriate treatment. Fraction of exhaled nitric oxide (FeNO) measurement is a valuable non-invasive diagnostic tool in determining the cause of prolonged cough in children. Although there are several studies on asthma and COPD, there is a lack of them on other lung diseases such as tuberculosis, bronchiectasia, bronchiolitis obliterans (BO), and pneumonia. PATIENTS AND METHODS: In this study, pretreatment FeNO levels of patients with various lung diseases were measured and results from the sick patient groups were compared with the results from the control group. RESULTS: Pre-treatment FeNO levels in BO, asthma, and tuberculosis patient groups were higher than in the control group (p < 0.001). There was no significant difference between the acute bacterial pneumonia and bronchiectasia groups, and the control group (p > 0.05). CONCLUSIONS: FeNO measurement is a highly important guiding tool in diagnosis and treatment of various lung diseases.eninfo:eu-repo/semantics/closedAccessChildhoodAsthmaPulmonary DiseaseExhaled Nitric OxideFeNO levels in children with asthma and other diseases of the lungFeNO levels in children with asthma and other diseases of the lungArticle172230783082WOS:0003280853000162-s2.0-8489180786424302190Q2Q4